Darwin Global Management, Ltd. - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Darwin Global Management, Ltd. held in its portfolio 6 assets valued at $4,939,420,175 (i.e. $4.94B).

The most valuable assets in the portfolio included: INSMED INC ($3.64B), BELITE BIO INC ($486.92M), and ABIVAX SA ($439.71M).

The chart below shows the top 6 valuable assets, and the table below shows the top 6 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Darwin Global Management, Ltd. Portfolio

INSMED INC

BELITE BIO INC

ABIVAX SA

CIDARA THERAPEUTICS INC

WAVE LIFE SCIENCES LTD

CAPRICOR THERAPEUTICS INC

Darwin Global Management, Ltd. - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
INSMED INC	20933277	3644274193	COM PAR $.01
BELITE BIO INC	3027704	486915357	SPONSORED ADS
ABIVAX SA	3178501	439713828	SPONSORED ADS
CIDARA THERAPEUTICS INC	997196	220180877	COM NEW
WAVE LIFE SCIENCES LTD	7298421	125167920	SHS
CAPRICOR THERAPEUTICS INC	800000	23168000	COM NEW